CVE-2017-2125
Privilege escalation vulnerability in CentreCOM AR260S V2 remote authenticated attackers to gain...
Privilege escalation vulnerability in CentreCOM AR260S V2 remote authenticated attackers to gain privileges via the guest account.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- Low
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
NVD Score used
8.8
Privilege escalation vulnerability in CentreCOM AR260S V2 remote authenticated attackers to gain privileges via the guest account.
- Record
CVE-2017-2125- CVSS 3.0
- 8.8 High
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - CVSS 2.0
- 6.5 Medium
AV:N/AC:L/Au:S/C:P/I:P/A:P - Updated
- 2026-11-02
CVE List No score
Privilege escalation vulnerability in CentreCOM AR260S V2 remote authenticated attackers to gain privileges via the guest account.
- Record
CVE-2017-2125- Updated
- 2026-11-02
EUVDEUVD-2017-11308 No score
Privilege escalation vulnerability in CentreCOM AR260S V2 remote authenticated attackers to gain privileges via the guest account.
- Record
EUVD-2017-11308- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-r22m-g7h4-h52r
8.8
Privilege escalation vulnerability in CentreCOM AR260S V2 remote authenticated attackers to gain...
Privilege escalation vulnerability in CentreCOM AR260S V2 remote authenticated attackers to gain privileges via the guest account.
- Record
GHSA-r22m-g7h4-h52r- CVSS 3.0
- 8.8 High
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2017-2125 is a high vulnerability (CVSS 8.8) in Allied Telesis K.k. Centrecom, published April 28, 2017. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.92%, the 79th percentile. No source names a fixed version.